AIM
Axiom Investment Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $355K | Buy |
6,924
+2,254
| +48% | +$115K | 0.92% | 35 |
|
|
2022
Q3 | $206K | Sell |
4,670
-11,489
| -71% | -$507K | 0.41% | 54 |
|
|
2022
Q2 | $844K | Sell |
16,159
-1,785
| -10% | -$93.2K | 2.43% | 9 |
|
|
2022
Q1 | $927K | Sell |
17,944
-1,952
| -10% | -$101K | 2.02% | 10 |
|
|
2021
Q4 | $1.18M | Sell |
19,896
-9,535
| -32% | -$565K | 1.14% | 19 |
|
|
2021
Q3 | $1.27M | Sell |
29,431
-2,973
| -9% | -$128K | 1.28% | 18 |
|
|
2021
Q2 | $1.27M | Sell |
32,404
-1,941
| -6% | -$76.2K | 0.99% | 24 |
|
|
2021
Q1 | $1.24M | Buy |
34,345
+33,420
| +3,613% | +$1.21M | 1.01% | 20 |
|
|
2020
Q4 | $722 | Sell |
925
-18,854
| -95% | -$14.7K | 0.66% | 39 |
|
|
2020
Q3 | $727K | Buy |
19,779
+12,478
| +171% | +$459K | 0.82% | 32 |
|
|
2020
Q2 | $241K | Buy |
7,301
+449
| +7% | +$14.8K | 0.32% | 88 |
|
|
2020
Q1 | $223K | Sell |
6,852
-1,100
| -14% | -$35.8K | 0.39% | 75 |
|
|
2019
Q4 | $313K | Sell |
7,952
-50,863
| -86% | -$2M | 0.45% | 70 |
|
|
2019
Q3 | $2.12M | Sell |
58,815
-167,130
| -74% | -$6.01M | 1.62% | 12 |
|
|
2019
Q2 | $9.77M | Sell |
225,945
-2,395
| -1% | -$104K | 1.76% | 5 |
|
|
2019
Q1 | $9.67M | Sell |
228,340
-1,705
| -0.7% | -$72.2K | 1.84% | 7 |
|
|
2018
Q4 | $10M | Buy |
+230,045
| New | +$10M | 2.12% | 4 |
|